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Solving difficult hepatobiliary problems in children
A J W Millar
Most difficult hepatobiliary (HPB) problems in infancy and childhood 
result from pathological anatomical/mechanical derangements; 
therefore, surgery on the liver and bile ducts depends on a detailed 
understanding of liver structure, function and repair response to 
injury or disease.¹ Most importantly, the surgeon should be aware 
of the very diverse range of anatomical variations. Perhaps key 
to improved outcomes in paediatric HPB surgery is centralised 
management and associating this with a paediatric liver transplant 
programme, which adds expertise and, frequently, the added benefit 
of adult HPB surgical input to paediatric surgical care. This has been 




The surgery for biliary atresia (BA), initially proposed by Kasai in 
1959, has seen little change, although numerous modifications have 
been proposed.4 There is now remarkable consensus over most aspects 
of the surgery, but less in the role of the use of steroids, prophylactic 
antibiotics, choleretic agents and the prevention and treatment of 
cholangitis. With a combination of early surgery, pre-surgery gut 
sterilisation, minimally invasive open surgery (not laparoscopy), a high 
starting dose, short course and early taper steroid protocols, antibiotic 
prophylaxis and choleretics (ursodeoxycholic acid, cholestyramine 
and phenobarbitone), >80% sustained clearance of jaundice has been 
achieved.5 This has led to a reduced number of infants and children 
requiring liver transplantation during the childhood years. Although 
this may only delay the need for liver transplantation (about 85% of 
all BA cases eventually require transplantation even after a successful 
Kasai portoenterostomy), a childhood complicated by the need for 
immunosuppression can be avoided. 
The biliary tree should be approached via a right-sided transverse 
or oblique subcostal incision, which can be extended across the 
midline. A laparoscopic Kasai procedure has a poorer long-term 
outcome and is currently not recommended.6  If a diagnosis has not 
been established pre-operatively, then an operative cholangiogram 
should be performed via a catheter in the gallbladder. If there is bile 
in a normal-looking gallbladder, a diagnosis of BA can be excluded, 
provided that patency of the common bile duct to the duodenum 
is shown. A gallbladder filled with clear mucus suggests type 2 BA 
and a cholangiogram may show a thinly patent bile duct but absent 
proximal ducts. At this stage, only complete visualisation of the whole 
biliary tree can exclude BA. The hepatic suspensory ligaments may be 
divided and the liver rotated anteriorly to expose its inferior surface 
in the incision. It is rarely necessary to ‘deliver’ the liver through the 
incision. Although this manoeuvre provides good exposure to the 
porta hepatis, possible adverse effects include congestion of the liver 
and, on occasion, acute impairment of venous return and cardiac 
asystole. A folded swab can be placed posterior to the right lobe to 
lift the liver forward. The gallbladder remnant should be dissected 
off the liver and the obliterated common biliary tract divided distally. 
Using the gallbladder remnant for gentle traction, the residual fibrotic 
bile duct should be elevated to separate it from the underlying portal 
vein and adjacent hepatic artery and then dissected free from the 
right and left branches of the portal vein. There is debate as to how 
far laterally the dissection should be extended. It is usually sufficient 
to stop where the hepatic artery enters the liver parenchyma. Small 
portal venous radicles entering the caudate lobe must be ligated and 
divided with fine sutures to expose the posterior aspect of the portal 
plate. After the portal plate has been fully dissected, a 35 - 40 cm 
long Roux limb of jejunum, brought up through the mesentery of 
the transverse colon, must be created. The proximal transection of 
jejunum should be close (approximately 10 cm) to the duodenojejenal 
(DJ) flexure. The open end should be sutured or ligated closed and 
inverted with a purse-string suture. The blood supply and venous 
drainage from the Roux limb should be fully preserved. The proximal 
end of the Roux must be incised and tailored to the size of the portal 
plate. The fibrotic portal plate must now be transected high at the 
level of the porta hepatis without entering the liver parenchyma. This 
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is best performed using super-cut curved scissors, commencing on 
the left lateral aspect. Bleeding from the cut surface of the portal plate 
should be minimal. Traction sutures placed in the caudate lobe may 
facilitate exposure. A complete resection of the extrahepatic biliary 
tree is advisable in all types of BA, except for the uncommon case in 
which there is a significant remnant of patent bile duct in the porta 
hepatis. Biliary continuity should be restored using the Roux limb, 
which is anastomosed to the transected tissue in the porta hepatis as 
a portoenterostomy with continuous or interrupted 5/0 absorbable 
sutures. The posterior layer of sutures should be placed well clear of 
the transected portal plate and the lateral and anterior layer should 
be placed superficially in Glisson’s capsule. The operation must be 
completed by ensuring that the defects in the mesentery are sutured 
closed and the Roux limb lies appropriately without twisting. Various 
types of valves have been advocated (mucosal flap and intussusception 
valves), but there is no strong evidence for their efficacy.7 A drain is 
unnecessary. In some BA cases, operative cholangiography may show 
a patent lower common bile duct in continuity with the gallbladder, 
with the atretic process restricted to the common hepatic and hepatic 
ducts. Reconstruction of the biliary tract using the gallbladder 
(portocholecystostomy) after resection of the remnants of the bile 
ducts has been suggested to be effective in preventing post-operative 
cholangitis. However, obstructive post-operative complications are 
frequent with this technique and it has largely been abandoned. 
Post-operative care and long-term complications
Antibiotics are administered intravenously (IV) in the immediate 
post-operative period and replaced by oral antibiotic prophylaxis after 
the return of bowel activity. This can be continued for the first year 
according to protocol. Choleretics (cholestyramine, ursodeoxycholic 
acid (10 mg/kg/dose twice daily) and phenobarbitone (5 mg/kg/dose 
nocte)) and vitamins A, D, E, and K are also prescribed for at least 
1 year. Ranitidine (1 mg/kg/dose 3 times daily) is administered for 
gastric protection for the duration of the course of steroids. Steroids 
have been recommended on the basis that they may reduce scar 
tissue formation and improve bile flow after portoenterostomy; no 
controlled trials have confirmed or refuted their efficacy, although 
observational evidence supports their use. Dose, time of treatment 
initiation and duration vary widely; prospective trials are in progress 
to define best practice.8 The best available evidence suggests that a 
short course of initial high-dose steroid (4 - 5 mg/kg/day) with rapid 
tapering is the most effective: 
• Steroids (an optional 2-week course): e.g. 20 mg methylprednisolone 
(IV) on day 1, decreasing to 2.5 - 5 mg/day, followed by 5 mg 
prednisolone (oral) daily  for 1 week
• Antibiotics (IV) for 5 days: gentamicin (2.5 mg/kg/dose) 3 times 
daily (levels needed) and amoxicillin (25 mg/kg/dose) 3 times 
daily
• Antibiotic prophylaxis (started on post-operative day 6): 
cephalexin (12.5 mg/kg/dose) twice daily for 1 month, or 
ciprofloxacin (5 - 10 mg/kg/dose) twice daily (oral) with 
extended prophylaxis (od) dose. 
Complications of portoenterostomy include: ascending 
bacterial cholangitis, cirrhosis, portal hypertension, metabolic and 
nutritional consequences of cholestasis, intrahepatic cyst formation, 
hepatopulmonary syndrome, pulmonary hypertension, and 
malignant change in the liver (rare).
Ascending bacterial cholangitis
This serious complication is most common in the first year following 
portoenterostomy. Episodes of infection occur in approximately 40 
- 50% of the infants, most commonly in those who have achieved 
at least some degree of bile flow. The complication, characterised 
by worsening jaundice, fever and acholic stools, is diagnosed 
by blood culture, percutaneous liver biopsy or aspiration blood 
culture. A wide range of causative organisms may be identified, 
including Escherichia coli, Proteus and Klebsiella species, but 
suspected cases must be treated early and empirically with broad-
spectrum antibiotics (e.g. ceftazidime, amoxicillin, ciprofloxacin 
and gentamicin or piperacillin and amikacin), before the detailed 
results of investigations are available.
Several operative modifications have been made to Kasai’s original 
portoenterostomy to reduce the incidence of cholangitis, including 
diversion stomas and the formation of anti-reflux valves in the limb of 
the Roux loop. Despite the theoretical benefits of such modifications, 
in practice they confer little additional benefit, and equally good 
results are obtained from the use of a long Roux loop.
Cholangitis may occur some years after portoenterostomy in 
children with otherwise good liver function. In such cases, partial 
obstruction of the Roux loop, perhaps secondary to an adhesion or 
twist in the loop, must be excluded, as this can be relieved by surgery. 
Percutaneous trans-hepatic cholangiography (PTC) and radionuclide 
hepatic imaging are essential to identifying the site of the obstruction 
in these cases. Prolonged antibiotic prophylaxis may be unnecessary, 
particularly if there is no obstruction of the Roux loop. If cholangitis 
recurs frequently despite these measures and with deteriorating liver 
function, then liver transplantation should be considered. 
Results
Several variables have been studied to predict the effectiveness of 
portoenterostomy; some derived from peri-operative data, e.g. age 
at surgery, macroscopic appearance of the bile ducts, microscopic 
analysis of the resected specimen, and liver histopathology.2,9 The 
extent of histological abnormality (degree of fibrosis) at the time of 
surgery may indicate a poorer prognosis, but this finding has not 
been consistent. The degree of portal hypertension at the time of 
the procedure is correlated with a shorter time to requiring liver 
transplantation, reflecting liver pathophysiology in a more functional 
way.10 Although disputed, the surgeon’s experience has also been 
implicated as an important prognostic factor.11 In a personal series 
of patients operated on at a mean age of 52 days over a 3.5-year 
period (2004 - 2007), clearance of jaundice was achieved in 23/29 
cases (79%). Perhaps more importantly, improved outcome has been 
associated with greater centre caseload (and consequently, greater 
experience), and better communication between major centres and 
peripheral units.12 The age at which surgery is performed is the single 
most widely quoted prognostic variable, although some have shown 
little relationship in infants aged <10 weeks.13,14 However, in infants 
older than 100 days at the time of portoenterostomy, uncorrected 
atresia of the bile ducts results in progressive intrahepatic disease and 
a clear detrimental effect of age on survival has been demonstrated. 
In summary, the post-operative volume of bile flow is probably 
related to the size of bile ductules at the porta hepatis, while the long-
term quality of survival in those with adequate bile flow depends on 
the severity of secondary liver damage at the time of surgery and the 
incidence and severity of post-operative cholangitis.13,15,16
Approximately 70 - 80% of infants show evidence of bile flow 
after surgery, which is adequate to ensure survival to 5 years 
of age in >65% of cases, reducing the need for paediatric liver 
transplantation. Furthermore, series from Japan, France, the USA 
and the UK suggest that 30 - 40% of paediatric patients survive to 10 
years of age with their native liver intact following portoenterostomy, 
although approximately 40% have abnormal results on liver function 
tests. In a French series, 23% (63/212) of patients who underwent 
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portoenterostomy between 1968 and 1983 were alive with their 
native liver intact 20 years after surgery, although all but 2 had signs 
of cirrhosis.17
Choledochal cysts
Total cyst excision has been the treatment of choice for decades. A 
cholangiogram is performed if the anatomy of the cyst has not been 
defined pre-operatively with ultrasound, computed tomography 
or magnetic resonance cholangiopancreatography. A sample of 
bile should be taken for amylase, lipase and culture testing. The 
extrahepatic cyst must be excised completely, keeping to the relatively 
avascular plane just deep to the peritoneum. Distal excision should 
be complete down to the level of the pancreatic duct junction, which 
can be confirmed endoscopically using a choledochoscope or, if not 
available, a paediatric cystoscope in the case of fusiform cysts with 
pancreaticobiliary malunion. A vessel loop passed around the cyst 
is useful to lift it clear of the portal vein. The proximal anastomosis 
should ideally be at the level of the right and left hepatic duct 
confluence, without leaving a cuff of residual cyst. The cyst should 
not be excised too high in the porta hepatis, as it is easy to cut off 
the cyst above the entrance of the right and left hepatic ducts into 
the cyst. Extending the width of the anastomosis by incising along 
the left hepatic duct, which usually lies outside of the liver, avoids 
stenosis.18 Roux-en-Y biliary enteric drainage is the preferred route, 
as long-term bile reflux gastritis occurs in up to 25% of cases where 
a hepatico-duodenostomy has been performed. Minimally invasive 
techniques are popular in Asia where choledochal cysts are more 
commonly seen; the simpler hepatico-duodenostomy procedure 
appears to be favoured.19,20
Foregut atresia and biliary anomalies
These anomalies, noted with increasing frequency, include the 
hepatocystic duct where the common hepatic or right hepatic 
duct inserts into the gallbladder, choledochal cysts, stenosis and 
choledochocoele.21
Portal hypertension
The meso-Rex shunt, first described by de Ville de Goyet22 using an 
autologous internal jugular vein graft, is now the preferred method 
of treatment for portal cavernoma.23 There have been several further 
technical innovations including use of the coronary vein, inferior 
mesenteric vein and spliced saphenous veins when the jugular vein 
is not available. Selective shunts are preferred if the Rex vein is not 
patent (30% of cases) and oesophageal varices are not controlled by 
banding or sclerotherapy. Outcomes are excellent, with long-term 
vein patency in nearly all cases, and good evidence of restoration 
of hepatic nutrition, with increased liver growth, resolution of the 
cavernoma and biliopathy, a reduction in spleen size, and an added 
bonus of improved intellectual performance.24,25
Budd-Chiari syndrome
This rare but devastating disease, which may be associated with a 
thrombophilic diathesis or anatomical web, can be managed in the 
early stages with trans-jugular stenting. The Senning hepato-atrial 
patch operation is less commonly used, but can be successful. If liver 
cirrhosis is established, then transplantation is indicated.26-28 
Hepatic vascular tumours and 
malformations
Glucose transporter-1 (GLUT-1)-negative infantile haemangiomas 
may not respond to propranolol and steroids. If the infant is small and 
unstable due to cardiac failure, thrombocytopenia and/or jaundice, 
then hepatic artery ligation may be a simpler, effective and indeed 
less invasive intervention than embolisation. Laparoscopic occlusion 
of the main feeding arteries is also effective. Transplantation has been 
used as a last resort in a few cases.29 
Tumour surgery
Extending the limits of hepatic resection has become a fine art.30- 32 
Perhaps in some cases this is a bridge too far, as ill-advised and 
poorly conducted extended hepatic resections may lead to early 
post-operative liver failure and/or the necessity for emergency 
liver transplantation. Also, transplantation after local recurrence 
following resection has a poorer outcome. Good surgical exposure 
is achieved by a large subcostal incision, which can be extended 
to the xiphisternum in the midline, and by using one of the self-
retaining retractor systems. Intra-operative ultrasound can define 
the exact relationship between the area to be resected and the major 
venous anatomy. Obstructed and dilated bile ducts can be cut flush 
with the residual cut surface of the liver and drained with a Roux-
en-Y hepaticojejunostomy.33  If the extrahepatic bile ducts are to 
be preserved, it is essential to ensure that arterial supply has not 
been compromised. Inflow occlusion (Pringle) is routine and it is 
wise to have control of the inferior vena cava above and below the 
liver prior to commencing resection. Occasionally, total vascular 
exclusion is useful to control bleeding. Many technical aids are 
available for parenchymal transaction, but personal preference is 
for non-stick bipolar diathermy and titanium haemostatic clips. 
Topical haemostatic agents can help with ooze, and the Argon beam 
coagulator helps with haemostasis over a large cut section, but the 
Argon is a ‘luxury’ in my opinion. A vascular stapler for the hepatic 
veins is particularly useful in larger children. The key to successful 
resection is to mobilise the liver fully off the retrohepatic inferior 
vena cava and subsequently define and control the vascular inflow 
and the hepatic venous outflow to the sector(s) to be resected. Great 
care should be taken to ligate or clip the venous connections from 
segments 8 and 1 to avoid bleeding from the cava or under-surface 
of the liver. Low central venous pressure helps to minimise blood 
loss. Further ‘tips and tricks’: (i) taking too much liver and leaving 
a remnant at risk for ‘small-for-size’ syndrome can be avoided by 
pre-operative portal vein embolisation/ligation, allowing for growth 
of the proposed liver remnant prior to resection; (ii) avoid hepatic 
congestion by ensuring that there is no hepatic venous outflow 
obstruction from torsion/kinking of the residual liver remnant; and 
(iii) reduce inflow perfusion with somatostatin infusion, splenic 
artery ligation and even temporary partial porto-systemic shunting. 
In the post-operative period, management includes medical support 
for the liver with infusion of fresh-frozen plasma to maintain 
haemostasis and protein C levels and N-acetyl cysteine infusion as 
prophylaxis against metabolic liver failure. Where the hepatic veins 
are involved by tumour, a ‘proximal’ hepatectomy can be performed 
safely if sufficiently large accessory right hepatic Baer’s vein(s) are 
draining the residual liver into the inferior vena cava.34 Ex vivo 
perfusion and bench surgery have also been performed successfully 
for the rare benign tumour involving the cavo-hepatic confluence. 
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